A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.
Status:
Recruiting
Trial end date:
2024-06-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the safety, tolerability, and PK (measurement of drug
activity in the body over time) of AZD7503 injected subcutaneously, and compared to placebo,
in participants with suspected NASH, a type of liver disease.